| Identification | Back Directory | [Name]
Aganepag (Synonyms: AGN 210937) | [CAS]
910562-18-4 | [Synonyms]
Aganepag
AGN 210937
Aganepag (AGN 210937)
Aganepag (Synonyms: AGN 210937) | [Molecular Formula]
C24H31NO4S | [MDL Number]
MFCD30532715 | [MOL File]
910562-18-4.mol | [Molecular Weight]
429.57 |
| Chemical Properties | Back Directory | [Boiling point ]
678.6±55.0 °C(Predicted) | [density ]
1.212±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [form ]
Solid | [pka]
3.70±0.10(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Aganepag is a potent Prostanoid EP2 receptor agonist, with an EC50 of 0.19 nM, and shows no activity at EP4 receptor. Aganepag can be used in the research of wound healing, scar reduction, scar prevention and wrinkle treatment and prevention. | [IC 50]
EP2: 0.19 nM (EC50) | [storage]
Store at -20°C | [References]
[1] Robert M. Burk, et al. Compounds and methods for skin repair. WO2014078434A1 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310; |
| Website: |
https://www.weikeqi-biotech.com/ |
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|